Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

January 12, 2021
Open Access

Life Course Air Pollution Exposure and Cognitive Decline: Modelled Historical Air Pollution Data and the Lothian Birth Cohort 1936

Journal of Alzheimer's Disease : JAD
Tom C RussJamie R Pearce
January 10, 2021

Longitudinal changes in network homogeneity in presymptomatic C9orf72 mutation carriers

Neurobiology of Aging
Rebecca E WaughMary Kay Floeter
January 8, 2021
Open Access

Impact of Hearing Loss on Geriatric Assessment

Clinical Interventions in Aging
Christiane VölterJan Peter Thomas
January 7, 2021

Venous dysfunction plays a critical role in "normal" white matter disease of aging

Medical Hypotheses
Anish Kapadia, Adam A Dmytriw
January 6, 2021

'We're not doing it to be nasty': Caregivers' ethical dilemmas in negotiating driving safety with older adults

Canadian Journal on Aging = La Revue Canadienne Du Vieillissement
Michelle N LafranceCarmen Poulin
January 12, 2021
Open Access

Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19

Journal of Cellular Immunology
Alexander YangBing Yang
January 9, 2021
Open Access

Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration

ACS Chemical Neuroscience
Debasis PatnaikStephen J Haggarty
January 8, 2021

Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease

William J JagustAlzheimer’s Disease Neuroimaging Initiative
January 8, 2021
Open Access

Anxiety, Impaired Social and Aggressive Behaviour Correlates With Cognitive Decline Accompanied by Molecular Alterations in Older SAMP8 Males
Foteini VasilopoulouChristian Griñán-Ferré
January 9, 2021

Cognitive Impairment in Patients with Stroke

Seminars in Neurology
Caitlin E D'SouzaJames F Meschia
January 14, 2021

Preventing Dementia? Interventional Approaches in Mild Cognitive Impairment

Neuroscience and Biobehavioral Reviews
Vanessa Lissek, Boris Suchan
January 7, 2021

Memory-relevant nap sleep physiology in healthy and pathological aging

Julia LadenbauerAgnes Flöel
January 15, 2021
Open Access

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment

Dementia and Geriatric Cognitive Disorders Extra
Raul VintimillaSid O'Bryant
January 8, 2021
Open Access

Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain

Acta Neuropathologica Communications
Joanna J BuryCognitive Function and Ageing Study
January 13, 2021
Clinical Trial
Open Access

Recruitment and Baseline Characteristics of Participants in the Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline

International Journal of Environmental Research and Public Health
Susanne RöhrSteffi G Riedel-Heller
January 11, 2021
Open Access

Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain

Neurobiology of Aging
Ryan K ShahidehpourAdam D Bachstetter
January 6, 2021
Open Access

Differential transcript usage unravels gene expression alterations in Alzheimer's disease human brains

Npj Aging and Mechanisms of Disease
Diego Marques-CoelhoMarcos Romualdo Costa

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2021 Meta ULC. All rights reserved